浙江大学医学院附属第二医院，简称浙医二院，又名浙江省第二医院，是附属于浙江大学医学部的一所三级甲等医院。位于杭州市解放路88号。

During the past decade, The Second Affiliated Hospital of Zhejiang University, School of Medicine conducted 591 clinical trials. In the 10-year time frame, 591 clinical trials started and 39 clinical trials were completed, i.e. on average, 6.6% percent of trials that started reached the finish line to date. In the past 5 years, 410 clinical trials started and 36 clinical trials were completed. i.e. 8.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Second Affiliated Hospital of Zhejiang University, School of Medicine" #1 sponsor was "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 338 trials, followed by "Eli Lilly and Company" with 17 trials sponsored, "Zhejiang University" with 15 trials sponsored, "Hoffmann-La Roche" with 13 trials sponsored and "BeiGene" with 13 trials sponsored. Other sponsors include 239 different institutions and companies that sponsored additional 142 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Second Affiliated Hospital of Zhejiang University, School of Medicine" #1 collaborator was "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 22 trials as a collaborator, "First Affiliated Hospital of Wenzhou Medical University" with 20 trials as a collaborator, "Sir Run Run Shaw Hospital" with 16 trials as a collaborator, "Huizhou Municipal Central Hospital" with 15 trials as a collaborator and "Taizhou Hospital" with 15 trials as a collaborator. Other collaborators include 1156 different institutions and companies that were collaborators in the rest 618 trials.

According to Clinical.Site data, the most researched conditions in "The Second Affiliated Hospital of Zhejiang University, School of Medicine" are "Colorectal Cancer" (16 trials), "Breast Cancer" (13 trials), "Stroke" (12 trials), "Non-small Cell Lung Cancer" (10 trials) and "Epilepsy" (8 trials). Many other conditions were trialed in "The Second Affiliated Hospital of Zhejiang University, School of Medicine" in a lesser frequency.

Most popular intervention types in "The Second Affiliated Hospital of Zhejiang University, School of Medicine" are "Drug" (313 trials), "Other" (86 trials), "Device" (83 trials), "Procedure" (68 trials) and "Biological" (40 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (53 trials), "Capecitabine" (12 trials), "placebo" (10 trials), "Carboplatin" (9 trials) and "Docetaxel" (9 trials). Other intervention names were less common.

The vast majority of trials in "The Second Affiliated Hospital of Zhejiang University, School of Medicine" are 599 trials for "All" genders, 32 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are 362 active trials in "The Second Affiliated Hospital of Zhejiang University, School of Medicine". 30 are not yet recruiting, 266 are recruiting, 59 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 146 completed trials in The Second Affiliated Hospital of Zhejiang University, School of Medicine, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in The Second Affiliated Hospital of Zhejiang University, School of Medicine, 50 "Phase 1" clinical trials were conducted, 107 "Phase 2" clinical trials and 138 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 45 trials, and there were also 160 trials that are defined as “Not Applicable".